Search

Ameya R Kirtane

age ~38

from Arlington, MA

Also known as:
  • Irtne K Ameya

Ameya Kirtane Phones & Addresses

  • Arlington, MA
  • Cambridge, MA
  • Somerville, MA
  • Quincy, MA
  • Minneapolis, MN
  • Boston, MA

Work

  • Company:
    University of minnesota
    Jan 2011
  • Address:
    Greater Minneapolis-St. Paul Area
  • Position:
    Graduate research assistant

Education

  • Degree:
    Doctor of Philosophy
  • School / High School:
    University of Minnesota-Twin Cities
    2010 to 2015
  • Specialities:
    Pharmaceutics

Skills

Drug Delivery • Hplc • Formulation • Pharmaceutics • In Vitro • Cell Culture • In Vivo • Pharmacokinetics • Fluorescence • Uv/Vis • Nanoparticles • Cancer • Chromatography • Cell • Fluorescence Microscopy • Analytical Chemistry • Lc Ms • Mass Spectrometry • Nmr • Small Animal Imaging • Drug Development • High Performance Liquid Chromatography • Cell Biology • Liquid Chromatography Mass Spectrometry

Languages

English • Hindi • Marathi • Gujarati

Awards

Housing and travel grant - Csl limited & absorption systems

Industries

Pharmaceuticals

Resumes

Ameya Kirtane Photo 1

Instructor In Medicine

view source
Location:
77 Massachusetts Ave, Cambridge, MA 02139
Industry:
Pharmaceuticals
Work:
University of Minnesota - Greater Minneapolis-St. Paul Area since Jan 2011
Graduate research assistant

University of Minnesota Aug 2010 - May 2012
Teaching assistant

Northeastern University - Greater Boston Area Sep 2008 - Jul 2010
Graduate research assistant

K.B. Institute of Pharmaceutical Education and Research Nov 2007 - Feb 2008
Research assistant
Education:
University of Minnesota-Twin Cities 2010 - 2015
Doctor of Philosophy, Pharmaceutics
Northeastern University 2008 - 2010
Master of Science, Pharmaceutics and drug delivery
Gujarat University 2004 - 2008
Bachelor of Pharmacy, Pharmacy
Skills:
Drug Delivery
Hplc
Formulation
Pharmaceutics
In Vitro
Cell Culture
In Vivo
Pharmacokinetics
Fluorescence
Uv/Vis
Nanoparticles
Cancer
Chromatography
Cell
Fluorescence Microscopy
Analytical Chemistry
Lc Ms
Mass Spectrometry
Nmr
Small Animal Imaging
Drug Development
High Performance Liquid Chromatography
Cell Biology
Liquid Chromatography Mass Spectrometry
Languages:
English
Hindi
Marathi
Gujarati
Awards:
Housing and Travel Grant
CSL Limited & Absorption Systems
This was a housing and travel award to attend the Globalization of Pharmaceutical Education and Network (GPEN) conference in Melbourne, Australia in Nov-Dec'12.

Us Patents

  • Residence Structures And Related Methods

    view source
  • US Patent:
    20190125667, May 2, 2019
  • Filed:
    Jun 21, 2018
  • Appl. No.:
    16/014549
  • Inventors:
    - Cambridge MA, US
    - Boston MA, US
    Carlo Giovanni Traverso - Newton MA, US
    Robert S. Langer - Newton MA, US
    Stacy Mo - Darien IL, US
    Tyler Grant - Brighton MA, US
    Mousa Jafari - Waltham MA, US
    Dean Liang Glettig - Cambridge MA, US
    Angela DiCiccio - San Francisco CA, US
    Omar Abouzid - Cambridge MA, US
    Ameya R. Kirtane - Quincy MA, US
  • Assignee:
    Massachusetts Institute of Technology - Cambridge MA
    The Brigham and Women's Hospital, Inc. - Boston MA
  • International Classification:
    A61K 9/00
    A61K 47/32
    A61K 31/7048
    A61K 47/34
    A61K 47/10
    A61K 31/65
  • Abstract:
    Residence structures, systems, and related methods are generally provided. Certain embodiments comprise administering (e.g., orally) a residence structure to a subject (e.g., a patient) such that the residence structure is retained at a location internal to the subject for a particular amount of time (e.g., at least about 24 hours) before being released. The residence structure may be, in some cases, a gastric residence structure. In some embodiments, the structures and systems described herein comprise one or more materials configured for high levels of active substances (e.g., a therapeutic agent) loading, high active substance and/or structure stability in acidic environments, mechanical flexibility and strength in an internal orifice (e.g., gastric cavity), easy passage through the GI tract until delivery to at a desired internal orifice (e.g., gastric cavity), and/or rapid dissolution/degradation in a physiological environment (e.g., intestinal environment) and/or in response to a chemical stimulant (e.g., ingestion of a solution that induces rapid dissolution/degradation). In certain embodiments, the structure has a modular design, combining a material configured for controlled release of therapeutic, diagnostic, and/or enhancement agents with a structural material necessary for gastric residence but configured for controlled and/or tunable degradation/dissolution to determine the time at which retention shape integrity is lost and the structure passes out of the gastric cavity. For example, in certain embodiments, the residence structure comprises a first elastic component, a second component configured to release an active substance (e.g., a therapeutic agent), and, optionally, a linker. In some such embodiments, the linker may be configured to degrade such that the residence structure breaks apart and is released from the location internally of the subject after a predetermined amount of time.
  • Topical Composition Comprising Glycerol Monolaurate

    view source
  • US Patent:
    20190022227, Jan 24, 2019
  • Filed:
    May 1, 2018
  • Appl. No.:
    15/967844
  • Inventors:
    - Minneapolis MN, US
    Ameya Kirtane - Minneapolis MN, US
    Ashley Haase - Minneapolis MN, US
  • International Classification:
    A61K 47/10
    A61K 9/00
    A61K 31/717
    A61P 31/00
  • Abstract:
    Certain embodiments of the invention provide a pharmaceutical composition suitable for topical administration that comprises more than about 5% (w/w) glycerol monolaurate (GML), as well as methods of preparing and using such compositions.
  • Functionalized Nanoparticles And Methods Of Use Thereof

    view source
  • US Patent:
    20180243423, Aug 30, 2018
  • Filed:
    Dec 13, 2017
  • Appl. No.:
    15/841145
  • Inventors:
    - Minneapolis MN, US
    Tanmoy Sadhukha - Minneapolis MN, US
    Ameya Kirtane - Minneapolis MN, US
  • Assignee:
    REGENTS OF THE UNIVERSITY OF MINNESOTA - Minneapolis MN
  • International Classification:
    A61K 47/42
    A61K 47/69
    A61K 49/00
    A61K 47/62
  • Abstract:
    Certain embodiments of the present invention provide functionalized nanoparticles and methods of use thereof. Certain embodiments provide nanoparticles functionalized with streptokinase. Certain embodiments of the present invention provide methods for treating a pathological fibrin associated disorder (e.g., cancer) in an animal.
  • Residence Structures And Related Methods

    view source
  • US Patent:
    20170266112, Sep 21, 2017
  • Filed:
    Dec 16, 2016
  • Appl. No.:
    15/382255
  • Inventors:
    - Cambridge MA, US
    - Boston MA, US
    Carlo Giovanni Traverso - Newton MA, US
    Robert S. Langer - Newton MA, US
    Stacy Mo - Darien IL, US
    Tyler Grant - Cambridge MA, US
    Mousa Jafari - Boston MA, US
    Dean Liang Glettig - Cambridge MA, US
    Angela DiCiccio - Santa Clara CA, US
    Omar Abouzid - Cambridge MA, US
    Ameya R. Kirtane - Quincy MA, US
  • Assignee:
    Massachusetts Institute of Technology - Cambridge MA
    The Brigham and Women's Hospital, Inc. - Boston MA
  • International Classification:
    A61K 9/00
    A61K 31/7048
    A61K 31/65
    A61K 47/34
    A61K 47/10
  • Abstract:
    Residence structures, systems, and related methods are generally provided. Certain embodiments comprise administering (e.g., orally) a residence structure to a subject (e.g., a patient) such that the residence structure is retained at a location internal to the subject for a particular amount of time (e.g., at least about 24 hours) before being released. The residence structure may be, in some cases, a gastric residence structure. In some embodiments, the structures and systems described herein comprise one or more materials configured for high levels of active substances (e.g., a therapeutic agent) loading, high active substance and/or structure stability in acidic environments, mechanical flexibility and strength in an internal orifice (e.g., gastric cavity), easy passage through the GI tract until delivery to at a desired internal orifice (e.g., gastric cavity), and/or rapid dissolution/degradation in a physiological environment (e.g., intestinal environment) and/or in response to a chemical stimulant (e.g., ingestion of a solution that induces rapid dissolution/degradation). In certain embodiments, the structure has a modular design, combining a material configured for controlled release of therapeutic, diagnostic, and/or enhancement agents with a structural material necessary for gastric residence but configured for controlled and/or tunable degradation/dissolution to determine the time at which retention shape integrity is lost and the structure passes out of the gastric cavity. For example, in certain embodiments, the residence structure comprises a first elastic component, a second component configured to release an active substance (e.g., a therapeutic agent), and, optionally, a linker. In some such embodiments, the linker may be configured to degrade such that the residence structure breaks apart and is released from the location internally of the subject after a predetermined amount of time.

Googleplus

Ameya Kirtane Photo 2

Ameya Kirtane

Ameya Kirtane Photo 3

Ameya Kirtane

Facebook

Ameya Kirtane Photo 4

Ameya Kirtane

view source
Ameya Kirtane Photo 5

Ameya Kirtane

view source
...

Get Report for Ameya R Kirtane from Arlington, MA, age ~38
Control profile